Abstract:Blanka Wolszczak-Biedrzycka, 1 Justyna Dorf, 2 Joanna Matowicka-Karna, 2 Violetta Dymicka-Piekarska, 2 Marzena Wojewódzka-&Zdotele&zacuteniakowicz, 3 Piotr &Zdotukowski, 4 Anna Zalewska, 5 &Lstrokukasz D&aogonbrowski, 6 Mateusz Maciejczyk 7 1 Department of Psychology and Sociology of Health and Public Health, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland; 2 Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, Bialystok, Poland; 3 Department of Emergency Medicine and Disasters, Medical University of Bialystok, Bialystok, Poland; 4 Department of Restorative Dentistry, Croydon University Hospital, London, UK; 5 Independent Laboratory of Experimental Dentistry, Medical University of Bialystok, Bialystok, Poland; 6 Medical Laboratory, "Diagnostyka" Olsztyn, Olsztyn, Poland; 7 Department of Hygiene, Epidemiology and Ergonomics, Medical University of Bialystok, Bialystok, Poland Correspondence: Blanka Wolszczak-Biedrzycka, Email Aim: COVID-19 triggers the overproduction of reactive oxygen species (ROS) which, in combination with a weakened antioxidant barrier, can lead to protein oxidation and lipid peroxidation. The aim of this study was to evaluate enzymatic and non-enzymatic antioxidants, the overall redox potential, and protein and lipid peroxidation products in COVID-19 patients, convalescents, and healthy subjects, and to the determine the diagnostic applicability of these parameters in COVID-19 patients. Materials and Methods: The study involved 218 patients with COVID-19, 69 convalescents, and 48 healthy subjects who were selected for the research based on age and sex. The study was conducted between 20 February 2021 and 20 November 2021 in Bia&lstrokystok, Poland. The antioxidant barrier, redox status, and oxidative damage products were assessed in serum/plasma samples with the use of colorimetric and spectrophotometric assays. Results: Glutathione reductase (GR) activity was higher, whereas total antioxidant capacity (TAC) was lower in COVID-19 patients than in convalescents (p< 0.0001) and the control group (p< 0.0001). The concentrations of advanced glycation end products (AGEs), advanced oxidation protein products (AOPP), 4-hydroxynonenal (4-HNE), and malondialdehyde (MDA) were higher in COVID-19 patients (p< 0.0001) and convalescents (p< 0.0001) than in the control group. AGEs were the most effective diagnostic biomarker for differentiating COVID-19 patients from the control group (AUC=0.9971) and convalescents from the control group (AUC=1.000). Conclusion: An infection with the SARS-CoV-2 disrupts the redox balance and increases protein oxidation and lipid peroxidation. AGEs fulfill the criteria for a potential diagnostic biomarker in COVID-19 patients and convalescents. Keywords: oxidative stress, redox biomarkers, antioxidants, COVID-19, SARS CoV-2 virus The pathogenesis of the infection caused by the SARS-CoV-2 has not been fully elucidated to date. The immune response to the infection is complex and highly individualized, which undoubtedly affects the severity of disease symptoms and complications after the infection. 1 Research has shown that severe COVID-19 is not directly caused by the SARS-CoV-2, but by the cytokine storm which increases the production of reactive oxygen species (ROS) that induce oxidative stress. 2 An infection caused by the SARS-CoV-2 leads to the activation of neutrophils and mononuclear phagocytic cells which are largely responsible for the massive release of ROS in lung tissues. 3 In addition, the SARS-CoV-2 reaches lung cells via the angiotensin-converting enzyme 2 (ACE2) receptor, and an imbalance between the rate of ROS production and antioxidant processes may lead to oxidative damage to proteins, lipids, and nucleic acids. 4 Glutathione (GSH) is one of the key components of the antioxidant barrier, and it can prevent the S1 subunit of the SARS-CoV-2 spike protein from binding to the ACE2 receptor in the lungs. 5 According to the literature, an endogenous deficiency of GSH and other antioxidants, including superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR), can affect the severity of COVID-19. 6 It is generally known that COVID-19 can lead to post-infection complications and increases the risk of inflammatory, 7,8 metabolic, and neurodegenerative diseases which are also caused by an oxidation-reduction (redox) imbalance. 9 Therefore, oxidative stress parameters and antioxidant levels should be compared in convalesce -Abstract Truncated-

Redox Biomarkers – An Effective Tool for Diagnosing COVID-19 Patients and Convalescents

Significance of nitrosative stress and glycoxidation products in the diagnosis of COVID-19

New insights into extracellular and intracellular redox status in COVID-19 patients

Evaluation of oxidative stress level: total antioxidant capacity, total oxidant status and glutathione activity in patients with COVID-19

Use of Biochemical Biomarkers to Evaluate the Role of Oxidative Stress in the Progression of COVID-19 Severity

Systemic redox imbalance in severe COVID‐19 patients

The Impact of Serum Levels of Reactive Oxygen and Nitrogen Species on the Disease Severity of COVID-19

Stable Nitroxide as Diagnostic Tools for Monitoring of Oxidative Stress and Hypoalbuminemia in the Context of COVID-19

Laboratory Puzzle of Oxidative Stress, Parameters of Hemostasis and Inflammation in Hospitalized Patients with COVID-19

Extracellular Oxidative Stress Markers in COVID-19 Patients with Diabetes as Co-Morbidity

Oxidative Stress-Related Mechanisms in SARS-CoV-2 Infections

Oxidative stress index can be a new marker related to disease severity in COVID-19

Persistent Post COVID-19 Endothelial Dysfunction and Oxidative Stress in Women

Preliminary Comparison of Molecular Antioxidant and Inflammatory Mechanisms Determined in the Peripheral Blood Granulocytes of COVID-19 Patients

Severe Glutathione Deficiency, Oxidative Stress and Oxidant Damage in Adults Hospitalized with COVID-19: Implications for GlyNAC (Glycine and N-Acetylcysteine) Supplementation

A Pilot Study on Oxidative Stress during the Recovery Phase in Critical COVID-19 Patients in a Rehabilitation Facility: Potential Utility of the PAOT® Technology for Assessing Total Anti-Oxidative Capacity

Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study

Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease

COVID-19: A Redox Disease-What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment

Oxidative stress and inflammatory markers in patients with COVID-19: Potential role of RAGE, HMGB1, GFAP and COX-2 in disease severity

Evaluation of Oxidative Stress and Endothelial Dysfunction in COVID-19 Patients